Unit 09, Office Tower
41st Floor, Room 4109 Convention Plaza 1 Harbour Road
Wan Chai
Hong Kong
852 2802 9886
https://www.sinobiopharm.com
版塊: Healthcare
行業: Biotechnology
全職員工: 25,806
名稱 | 頭銜 | 支付 | 行使價 | 出生年份 |
---|---|---|---|---|
Ms. Y. Y. Tse | Executive Chairwoman of the Board | 42.87M | 無 | 1992 |
Ms. Cheung Ling Cheng | Executive Vice Chairwoman of the Board | 38.03M | 無 | 1964 |
Ms. Mingqin Li | Senior VP & Executive Director | 1.3M | 無 | 1959 |
Mr. Zhoushan Tian | Executive Director | 2.02M | 無 | 1964 |
Mr. Hsin Tse | Senior VP & Executive Director | 6.52M | 無 | 1970 |
Mr. Eric S. Y. Tse | CEO & Executive Director | 24.96M | 無 | 1996 |
Mr. Ping Tse | Founder & Senior Executive Vice Chairman | 45.32M | 無 | 1952 |
Ms. Chun Ling Li | Chief Financial Officer | 無 | 無 | 1972 |
Sean Chen | Chief Strategy Officer | 無 | 無 | 無 |
Orphanides George | Chief Scientific Advisor of invoX | 無 | 無 | 無 |
集團業務覆蓋醫藥研發、生產和銷售全產業鏈,其產品包括多種生物藥、化學藥及中藥現代化製劑。
截至 2024年4月1日 止,中國生物製藥 的 ISS 管治質素評分為 7。 Pillar 分數正在審核中:4;董事會:2;股東權利:7;現金賠償:9。